But even these patients benefit from advances against cancer, the report said. Five-year survival rates have increased since ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

A new report shows the five-year survival rate for all cancers reached a historic 70%. About 2.1 million new cancer diagnoses ...

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

The American Cancer Society’s annual report found that 70% of patients now survive at least five years after diagnosis.

A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new ...

"Seven in 10 people now survive their cancer 5 years or more, up from only half in the mid-70s," Siegel said in a press ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

In 1970, only half of patients lived past five years. Now, at least 70 percent of U.S. cancer patients are surviving for at ...

The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...

The cartoonist died at 68, but more patients are living longer with the deadly disease.